Maternal Mortality is an Urgent Health Crisis.

Despite healthcare advances, maternal mortality and morbidity rates have risen in the United States since the 1990's. But this crisis most deeply impacts Black mothers. In New Jersey, the pregnancy-related death rate for Black women is nearly seven times higher than White women.

The Partnership for Maternal and Child Health of Northern New Jersey, with support from RWJBarnabas Health, is pleased to host this innovative conference. The Symposium provides physicians, nurses, public health professionals, other healthcare providers, and advocates with a review of current clinical issues impacting maternal health and perinatal safety in New Jersey and nationally. Renowned experts will discuss the factors contributing to perinatal morbidity and mortality and propose prevention strategies that direct and enhance hospital obstetrical care for both patients and providers.

This year's Symposium will be held virtually. We've added innovations to maximize your virtual experience. Registrants will have the ability to participate in the live online sessions, access recorded material for up to 30 days following the conference, and view bonus content. The conference will include networking lounges, interaction tools, and a virtual exhibit hall to promote collaboration and share information. 

If you would like to pay by check or need an invoice, please contact Sarah Muller-Robbins, Director of Education, at srobbins@pmch.org.

We share the State of New Jersey's Nurture NJ vision to reduce health disparities. Please read the Nurture NJ strategic plan.

Learning Objectives 

At the conclusion of this learning activity, the participant will able to: 

• Describe the concept of maternal immunization as a safe and effective way to improve maternal/infant health
• Discuss how racism and lack of diversity in healthcare has led to poor maternal and infant health outcomes in the Black community 
• Identify opportunities to improve maternal cardiac morbidity and mortality
• Describe potential for new models of prenatal care
• Identify red flags of human trafficking and how to effectively respond
• Discuss methods to address perinatal mood and anxiety disorders

Learning Outcomes 

Three months after attending the symposium, 75% of learners will be able to incorporate strategies for supporting maternal health and perinatal safety into their professional practice in order to provide improved patient care.

Disclosures 

• The symposium planners do not have any conflicts of interest to report for this activity.
• Geeta Swamy, MD discloses that she is a site investigator for COVID vaccine trials for Pfizer and is a consultant for Pfizer, GlaxoSmithKline, and Moderna.
• The remaining speakers do not have any conflicts of interest to report for this activity.

Acknowledgement of Commercial Support 

Commercial Support was provided by The Nicholson Foundation, Family Health Initiatives, and Horizon Blue Cross Blue Shield of New Jersey.

Successful Completion/Awarding of Certificates

To receive contact hours for this continuing education program, the registrant must sign-in for the webinar, attend the entire presentation and complete and submit an evaluation. A certificate of completion will be distributed within two weeks of the program date. 

Physicians 

AMA Credit Designation Statement: Saint Barnabas Medical Center designates this educational activity for a maximum of 4.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Accreditation Statement: Saint Barnabas Medical Center is accredited by the Medical Society of New Jersey (MSNJ) to provide continuing medical education for physicians. 

Disclosure Policy: It is the policy of Saint Barnabas Medical Center, Office of Continuing Medical Education to ensure balance, independence, transparency, objectivity and scientific rigor in all CME sponsored educational activities. All participating in the planning or implementation of a sponsored activity are expected to disclose to the audience any relevant financial relationships and to assist in resolving any conflict(s) of interest that may arise from the relationship. Presenters must also make a meaningful disclosure to the audience of their discussion of unlabeled or unapproved drugs or devises. This information will be available as part of the activity material.

“Patient Safety Committee Work Product - Confidentiality Protection and Restrictions on Disclosure Pursuant to N.J.S.A. 26:2H -12.25b. & N.J.A.C. 8:43E-10.0”

Nurses 

This program has been awarded 4.0 contact hours. 

The Partnership for Maternal and Child Health is approved as a provider of continuing nursing professional development by New Jersey State Nurses Association an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.   #P194-2/2023.

Approval status does not imply endorsement by the Partnership for Maternal and Child Health of Northern New Jersey, NJSNA or by ANCC of any commercial products discussed/displayed in conjunction with the educational activity.

Contact